Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Inventory: 2016-2024

Historic Change in Inventory for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to -$13.9 million.

  • Collegium Pharmaceutical's Change in Inventory rose 98.63% to -$96,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $20,000, marking a year-over-year increase of 100.15%. This contributed to the annual value of -$13.9 million for FY2024, which is 1.71% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Change in Inventory of -$13.9 million as of FY2024, which was up 1.71% from -$14.2 million recorded in FY2023.
  • Collegium Pharmaceutical's 5-year Change in Inventory high stood at $8.3 million for FY2020, and its period low was -$48.3 million during FY2022.
  • Over the past 3 years, Collegium Pharmaceutical's median Change in Inventory value was -$14.2 million (recorded in 2023), while the average stood at -$25.5 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first surged by 352.90% in 2020, then plummeted by 2,202.53% in 2022.
  • MRY analysis of 5 years shows Collegium Pharmaceutical's Change in Inventory stood at $8.3 million in 2020, then plummeted by 72.24% to $2.3 million in 2021, then plummeted by 2,202.53% to -$48.3 million in 2022, then skyrocketed by 70.65% to -$14.2 million in 2023, then grew by 1.71% to -$13.9 million in 2024.
  • Its Change in Inventory stands at -$13.9 million for FY2024, versus -$14.2 million for FY2023 and -$48.3 million for FY2022.